ELAN

Elanco Animal Health Incorporated
$25.54
-0.01 (-0.04%)
Mkt Cap 12.76B
Volume 3,312,823
52W Range 13.39-27.72
Sector Healthcare
Beta 1.69
EPS (TTM) -0.50
P/E Ratio -48.15
Revenue (TTM) 4.89B
Rev Growth (5Y) +7.6%
EPS Growth (5Y) N/A
AlphaVal · Fair Value
What we estimate one share is worth
$7.42
Overvalued strong signal
244.1% above fair value
Modeled from cash flows & growth.
AlphaQuality · Grade · Gated
How strong & durable the business is
F
Platform & Compounding FCF
30.0 / 100 pillar composite (overridden)
A platform business that compounds free cash flow — graded A–F vs. similar companies.

Company Description

Track Record

Showing latest 4 periods • Swipe for more
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
Revenue 4.71B 4.44B 4.42B 4.41B 4.76B 3.27B 3.07B 3.07B 2.89B 2.91B 2.91B
Net Income (232.00M) 338.00M (1.23B) (78.00M) (483.00M) (560.10M) 67.90M 86.50M (310.70M) (47.90M) (210.80M)
EPS -0.47 0.68 -2.50 -0.15 -0.97 -1.27 0.18 0.28 -0.87 -0.13 -0.59
Free Cash Flow 284.00M 394.00M 117.00M 268.00M 286.00M (351.90M) 26.70M 352.80M 75.20M 45.60M (93.50M)
FCF / Share 0.57 0.80 0.24 0.55 0.59 -0.80 0.07 1.12 0.21 0.13 -0.26
Operating CF 560.00M 541.00M 271.00M 452.00M 483.00M (41.00M) 224.10M 487.30M 173.80M 155.90M 6.60M
Total Assets 13.36B 12.61B 14.36B 15.49B 16.48B 17.69B 8.99B 8.96B 8.94B 8.10B N/A
Total Debt 4.02B 4.32B 5.77B 5.84B 6.32B 6.13B 2.35B 2.47B 0 0 N/A
Cash & Equiv 545.00M 468.00M 352.00M 345.00M 638.00M 495.00M 334.00M 474.80M 323.40M 258.80M N/A
Book Value 6.55B 6.10B 6.22B 7.29B 7.51B 8.48B 5.55B 5.20B 7.79B 7.03B N/A
Return on Equity -0.04 0.06 -0.20 -0.01 -0.06 -0.07 0.01 0.02 -0.04 -0.01 N/A
ELAN News
Will Elanco Animal Health (ELAN) Beat Estimates Again in Its Next Earnings Report?
Jul 15, 2026 09:10 AM · zacks.com
Elanco Confirms Date and Conference Call for Second Quarter 2026 Financial Results Announcement
Jul 08, 2026 04:00 AM · prnewswire.com
Is the Options Market Predicting a Spike in Elanco Animal Health Stock?
Jun 30, 2026 09:40 AM · zacks.com
Elanco to Launch Elanco Ventures with $25 Million Multi-Year Commitment to Accelerate Innovation in Animal Health
Jun 18, 2026 03:26 AM · prnewswire.com
Elanco Announces USDA Approval of TruCan™ Ultra Lyme-L4, the First and Only 1/2 mL Combination Vaccine for Lyme and Leptospirosis for Dogs
Jun 15, 2026 04:47 AM · prnewswire.com
Elanco CEO on rolling out New World screwworm vaccine: 'We're prepared'
Jun 04, 2026 03:23 PM · youtube.com
Elanco Animal Health Commits to Supporting U.S. Livestock Producers and Pet Owners in Fight Against New World Screwworm
Jun 04, 2026 02:26 AM · prnewswire.com
Jim Cramer Says He Feels 'Something Not Well' At Zoetis, Names A Rival As His Pick
Jun 03, 2026 04:05 AM · benzinga.com
New Research Reveals Pet Spending as a "Protected Budget Item" for Owners, Fueling Industry Resilience
Jun 03, 2026 03:26 AM · prnewswire.com
Elanco Animal Health Incorporated (ELAN) Presents at 46th Annual William Blair Growth Stock Conference Prepared Remarks Transcript
Jun 02, 2026 02:11 PM · seekingalpha.com